- Home
- BUUU vs CATX Comparison
BUUU vs CATX Comparison
Compare BUUU & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BUUU | CATX |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 305.2M | 355.0M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BUUU | CATX |
|---|---|---|
| Price | $28.39 | $3.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 66.9K | ★ 1.1M |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $347.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.54 | $1.96 |
| 52 Week High | $38.90 | $6.16 |
Technical Indicators
Market Signals| Indicator | BUUU | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 49.03 |
| Support Level | $14.73 | $2.82 |
| Resistance Level | $38.90 | $3.56 |
| Average True Range (ATR) | 4.38 | 0.17 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 31.58 | 18.87 |
Price Performance
Historical ComparisonAbout BUUU BUUU Group Limited Class A Ordinary Share
BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.